Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Department of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Brain. 2022 Apr 18;145(2):713-728. doi: 10.1093/brain/awab294.
Posterior cortical hypometabolism measured with 18F-fluorodeoxyglucose (FDG)-PET is a well-known marker of Alzheimer's disease-related neurodegeneration, but its associations with underlying neuropathological processes are unclear. We assessed cross-sectionally the relative contributions of three potential mechanisms causing hypometabolism in the retrosplenial and inferior parietal cortices: local molecular (amyloid and tau) pathology and atrophy, distant factors including contributions from the degenerating medial temporal lobe or molecular pathology in functionally connected regions, and the presence of the apolipoprotein E (APOE) ε4 allele. Two hundred and thirty-two amyloid-positive cognitively impaired patients from two cohorts [University of California, San Francisco (UCSF), and Alzheimer's Disease Neuroimaging Initiative (ADNI)] underwent MRI and PET with FDG, amyloid-PET using 11C-Pittsburgh Compound-B, 18F-florbetapir or 18F-florbetaben, and 18F-flortaucipir tau-PET in 1 year. Standard uptake value ratios (SUVRs) were calculated using tracer-specific reference regions. Regression analyses were run within cohorts to identify variables associated with retrosplenial or inferior parietal FDG standard uptake value ratios. On average, ADNI patients were older and were less impaired than the UCSF patients. Regional patterns of hypometabolism were similar between cohorts, although there were cohort differences in regional grey matter atrophy. Local cortical thickness and tau-PET (but not amyloid-PET) were independently associated with both retrosplenial and inferior parietal FDG SUVRs (ΔR2 = 0.09 to 0.21) across cohorts in models that also included age and disease severity (local model). Including medial temporal lobe volume improved the retrosplenial FDG model in the ADNI cohort (ΔR2 = 0.04, P = 0.008) but not for the UCSF (ΔR2 < 0.01, P = 0.52), and did not improve the inferior parietal models (ΔR2 < 0.01, P > 0.37). Interaction analyses revealed that medial temporal volume was more strongly associated with retrosplenial FDG SUVRs at earlier disease stages (P = 0.06 in UCSF, P = 0.046 in ADNI). Exploratory analyses across the cortex confirmed overall associations between hypometabolism and local tau pathology and thickness and revealed associations between medial temporal degeneration and hypometabolism in retrosplenial, orbitofrontal and anterior cingulate cortices. Finally, our data did not support hypotheses of a detrimental effect of pathology in connected regions or of an effect of the APOE ε4 allele in impaired participants. Overall, in two independent groups of patients at symptomatic stages of Alzheimer's disease, cortical hypometabolism mainly reflected structural neurodegeneration and tau, but not amyloid, pathology.
用 18F-氟脱氧葡萄糖(FDG)-PET 测量的后部皮质代谢低下是阿尔茨海默病相关神经退行性变的一个众所周知的标志物,但它与潜在的神经病理学过程的关系尚不清楚。我们在横断面评估了导致后扣带回和下顶叶皮质代谢低下的三种潜在机制的相对贡献:局部分子(淀粉样蛋白和 tau)病理学和萎缩,包括来自退化的内侧颞叶或功能连接区域的分子病理学的远处因素,以及载脂蛋白 E(APOE)ε4 等位基因的存在。来自两个队列[加利福尼亚大学旧金山分校(UCSF)和阿尔茨海默病神经影像学倡议(ADNI)]的 232 名淀粉样蛋白阳性认知障碍患者在一年内接受了 MRI 和 FDG-PET、使用 11C-Pittsburgh 化合物-B、18F-氟比他滨或 18F-氟比苯并进行的 PET,以及 18F-氟托西普 tau-PET。使用示踪剂特异性参考区域计算标准摄取值比值(SUVr)。在队列内进行回归分析,以确定与后扣带回或下顶叶 FDG SUVr 相关的变量。平均而言,ADNI 患者比 UCSF 患者年龄更大,认知障碍程度更低。虽然队列之间存在区域灰质萎缩的差异,但皮质代谢低下的区域模式相似。在包括年龄和疾病严重程度(局部模型)的模型中,皮质厚度和 tau-PET(但不是淀粉样蛋白-PET)与后扣带回和下顶叶 FDG SUVr 均独立相关(ΔR2 = 0.09 至 0.21)(跨越队列)。包括内侧颞叶体积可改善 ADNI 队列中后扣带回的 FDG 模型(ΔR2 = 0.04,P = 0.008),但不能改善 UCSF 的模型(ΔR2 < 0.01,P = 0.52),并且不改善下顶叶模型(ΔR2 < 0.01,P > 0.37)。交互分析显示,内侧颞叶体积与后扣带回 FDG SUVr 的相关性在疾病早期阶段更强(UCSF 中为 P = 0.06,ADNI 中为 P = 0.046)。皮层的探索性分析证实了代谢低下与局部 tau 病理学和厚度之间的总体关联,并揭示了内侧颞叶退化与后扣带回、眶额皮质和前扣带皮质代谢低下之间的关联。最后,我们的数据不支持连接区域中的病理学的有害影响或受损参与者中 APOE ε4 等位基因的影响的假设。总体而言,在处于阿尔茨海默病症状阶段的两个独立患者组中,皮质代谢低下主要反映了结构神经退行性变和 tau,但不是淀粉样蛋白病理学。